Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors
about
Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach.Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging.
P2860
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@ast
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@en
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@nl
type
label
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@ast
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@en
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@nl
prefLabel
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@ast
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@en
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@nl
P2093
P1476
Discovery of Isonicotinamides ...... n Synthase Kinase-3 Inhibitors
@en
P2093
Carol M Krause
Catherine R Burton
David R Langley
Gene M Dubowchik
Guanglin Luo
Hal A Lewis
John E Macor
Jonathan Lippy
Joseph Raybon
P304
P356
10.1021/ACS.JMEDCHEM.5B01550
P407
P577
2016-02-11T00:00:00Z